Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJ2AN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,499
Award facts
- Contract value 100% obligated
- $34,498.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,498.59 delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 ml auto-injector pens on June 4, 2025, with a completion date of June 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent is a specialty biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and other allergic conditions, making this procurement consistent with the company's extensive portfolio of federal medical product deliveries through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FJ2AN?
SPE2DB25FJ2AN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FJ2AN worth?
The government has obligated $34,499 on SPE2DB25FJ2AN.
Is contract SPE2DB25FJ2AN an order under another contract?
Yes. SPE2DB25FJ2AN is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ2AN competed?
The extent of competition for SPE2DB25FJ2AN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award